Management of Sudden Severe Sensorineural Hearing Loss (SSNHL) in a 27-Year-Old

Definition

Initial Assessment

History

• Onset and rate of progression (seconds/hours/days?)
• Associated symptoms: tinnitus, aural fullness (very common), vertigo/disequilibrium (~40% of cases)
• Recent viral URTI within 1 month (28% of patients report this)
• Noise exposure, head trauma, barotrauma, ear surgery
• Drug history (aminoglycosides, loop diuretics, cisplatin)
• Autoimmune/rheumatologic symptoms (Cogan's syndrome, lupus, Wegener's)
• Neurological symptoms (diplopia, dysphagia, ataxia - suggests central pathology)
• Contralateral ear status

Examination

• Otoscopy - exclude wax impaction, effusion, perforation, cholesteatoma
• Tuning fork tests (Weber/Rinne) to confirm sensorineural nature at bedside
• Cranial nerve exam
• Neurological screen

Investigations

Mandatory

Not Routinely Recommended

• Routine bloods/biochemistry are not recommended by AAO-HNS guidelines as a standard workup for ISSNHL
• CT is not the investigation of choice (MRI is superior)

Targeted (based on clinical suspicion)

• FBC, ESR/CRP if autoimmune disease suspected
• Lyme serology (endemic area exposure)
• VDRL/FTA-ABS (syphilis - treatable cause)
• Blood glucose (diabetes risk for steroid therapy)
• Thrombophilia screen if hypercoagulable state suspected (young patient)
• HIV if risk factors present

Aetiology to Consider in a 27-Year-Old

• Viral: Herpes simplex/zoster reactivation, CMV, mumps, EBV, influenza
• Vascular: Cochlear arterial occlusion, hypercoagulable states, vasospasm
• Autoimmune: Cogan's syndrome, SLE, Wegener's, relapsing polychondritis
• Neoplastic: Vestibular schwannoma (even in young patients), CPA meningioma, leukaemia
• Traumatic: Perilymph fistula (barotrauma, Valsalva), temporal bone fracture
• Infectious: Lyme, syphilis, meningitis
• Ototoxic: Aminoglycosides, cisplatin, loop diuretics
• Neurological: Multiple sclerosis (demyelination can cause sudden SNHL)

Management

Step 1 - Immediate (Emergency)

Step 2 - First-Line Treatment: Systemic Corticosteroids

• Prednisone 1 mg/kg/day (typically 60 mg/day; not to exceed 60 mg/day) as a single morning dose
• Duration: 10-14 days, then slow taper
• If partial recovery is noted at day 10, consider extending the full dose for another 10 days and repeat the cycle until no further improvement
• Oral steroids should be initiated within 2 weeks of symptom onset for maximal benefit

Step 3 - Intratympanic (IT) Steroids

• IT dexamethasone (4-24 mg/mL) or methylprednisolone (62.5 mg/mL)
• 0.3-0.5 mL injected to fill the middle ear
• Weekly or on several consecutive days; multiple protocols exist
• If salvage IT steroids are to be used, they must be given as soon as oral steroid failure is apparent, preferably within the first 2 weeks of the original insult

Important: The longer the interval between the insult and salvage IT steroids, the lower the chance of hearing recovery. - Cummings Otolaryngology

Step 4 - Hyperbaric Oxygen Therapy (HBOT)

• Initial therapy (within 2 weeks): HBOT may be offered as an option combined with steroid therapy
• Salvage therapy (within 1 month of onset): HBOT combined with steroids may be offered when there is incomplete response to initial treatment
• Not recommended as standalone therapy

Treatments NOT Routinely Recommended

• Antiviral therapy (acyclovir) - not recommended by AAO-HNS guidelines despite viral aetiology theories; however, if herpes zoster oticus (Ramsay Hunt syndrome) is the confirmed cause, antivirals + steroids are appropriate
• Thrombolytic therapy - not recommended
• Vasodilator therapy / vasoactive substances (rheological agents, carbogen, papaverine) - not recommended
• Diuretics - not recommended for ISSNHL
• Bed rest - not mandatory unless severe vertigo

Prognosis Factors in This Patient

Follow-Up

1. Repeat audiometry at end of treatment, then again at 6 months
2. If incomplete recovery: discuss IT steroid salvage (if not already used), and auditory rehabilitation
3. If recovery places the patient in an aidable range: hearing aids or implantable devices
4. Single-sided deafness: cochlear implantation is an option if hearing does not recover
5. If MRI identifies a vestibular schwannoma: refer to neurotology for management (observe vs. radiosurgery vs. microsurgery)

Summary Algorithm

Sudden severe SNHL in 27yo
        ↓
Urgent ENT review + PTA audiogram
        ↓
Rule out conductive cause (otoscopy, tuning forks)
        ↓
Treat as SSNHL: Oral prednisone 1 mg/kg/day x 14 days (start immediately)
        ↓
Arrange MRI (gadolinium) to exclude retrocochlear pathology
        ↓
If oral steroid failure → Salvage IT steroids ASAP (within 2 weeks of onset)
        ↓
Consider HBOT as adjunct (combined with steroids, if available)
        ↓
Repeat audiogram at end of treatment + 6 months
        ↓
Incomplete recovery → Audiology rehabilitation / hearing aids / CI assessment

Recent Evidence

• Clinical practice guidelines for acute SNHL (Kitoh et al., Auris Nasus Larynx, 2024, PMID 38968877) - Japanese CPG with systematic review; confirms steroid-based treatment as standard, adds evidence on IT steroids.
• High-dose vs standard-dose steroids (Balai et al., Auris Nasus Larynx, 2024, PMID 37127508) - systematic review comparing regimens; the 2024 NEJM Evidence RCT by Plontke et al. found high-dose glucocorticoids did not significantly outperform standard doses.
• Natural history without treatment (Ying et al., Laryngoscope, 2024, PMID 38808803) - meta-analysis confirms 30-65% spontaneous recovery rate, reinforcing but not replacing active treatment.
• Local IT glucocorticoid injections (Chen et al., Chin Otolaryngol, 2025, PMID 39842825) - meta-analysis supports IT steroids for hearing recovery.